Mallinckrodt PLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Mallinckrodt PLC
CIK #0001567892
EDGAR Form CIK 2011 - 2026
10-K [0001567892]
10-Q [0001567892]
3 [0001567892]
4 [0001567892]
5 [0001567892]
8-K [0001567892]
SC 13D [0001567892]
SC 13G [0001567892]
Form 13D/13G Filer Form 13D/13G Subject Filed
HEIN Park Capital Management LP Keenova Therapeutics PLC [2026-02-13]
GoldenTree Asset Management LP Mallinckrodt PLC [2025-08-07]
Marathon Asset Management LP Mallinckrodt PLC [2024-02-06]
HEIN Park Capital Management LP Mallinckrodt PLC [2024-01-17]
GoldenTree Asset Management LP Mallinckrodt PLC [2023-12-13]
Squarepoint Ops LLC Mallinckrodt PLC [2023-11-24]
Silver Point Capital LP Mallinckrodt PLC [2023-11-24]
Flynn James E Mallinckrodt PLC [2023-11-20]
Bracebridge Capital LLC Mallinckrodt PLC [2023-06-16]
Alta Fundamental Advisers LLC Mallinckrodt PLC [2023-06-16]
View All
Form 3/4/5 Subject 2011 - 2026
Donato Leslie E
Keenova Therapeutics PLC
Bisaro Paul
Zinman Jon
Yoskowitz Marc J
Langlois Sophia J
Hirsch Scott
Efron Paul
Dorton Katina
Silver Point Capital LP
Mule Edward A
O'shea Robert J
Williamson Susan Ann
Stouch Cheryl Ann
Basso Tracy
Honczarenko Marek
Nielsen Henriette
Olafsson Sigurdur O
ONeill Hugh Paul
Stamoulis Christiana
Tyndall Mark Anthony
French Lisa
GoldenTree Asset Management LLC
Tananbaum Steven A
GoldenTree Asset Management LP
Welch Stephen Andrew
Hussain Abbas
Wheeler Wesley
Stetson David J
Bradley Mark T
Richardson Peter C
Reasons Bryan M
Harrold Kassie
Goodson Jason Daniel
FFI III Sa rl
Olifant Luxco Sa rl
FYI Sa rl
Bracebridge Capital LLC
Silbermann Susan Michele
El-Dada Riad Hussein
Ling Karen
Celentano Daniel Arthur
Sulat James R
Myers Woodrow A Jr
Goldman Neal P
Alta Fundamental Advisers LLC
Paya Carlos V
Carroll J Martin
Reed Joann A
Youngblood Dr Kneeland
Trudeau Mark
Norton David Y
Carlucci David R
O'Neill Hugh M
Carter Paul Rutherford
Casey Mark J
Russell Angus C
Romano Steven J
Watkins Ian J
Whitaker Anne Clem
Schaefer Kathy A
Rosa-Bjorkeson Dagmar
Zaccagnino Joseph A
Sheehy Karen Patruno
Scholz Frank
Harbaugh Matthew K
Kegler George A
Deerfield Management Company LP
Deerfield Capital LP
Deerfield Partners LP
Flynn James E
Lloyd Ronald K
Booth Melvin D
Gulyas Diane H
Hicks Michael-Bryant
Lannum Coleman N III
Phillips Gary M
Fischer Meredith B
Thompson Virgil D
Furey Raymond J
Bailey Don M
Lurker Nancy
Carlson Terrance L
Edwards Peter G
Saltarelli Mario D
Hatten Sandra L
Tasse Daniel
Paulson & Co Inc
Merrick Stephen
Berry Thomas E
Enceladus Holding Ltd
Carchedi Stefano R
Keenan David
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 15,936 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 34,528 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 198,539 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 34,528 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 15,936 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 51,794 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 101,262 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 51,794 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 58,434 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-25 Grant 51,794 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-23 Grant 3,984 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-23 Grant 3,984 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-23 Grant 5,312 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-23 Grant 3,984 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-23 Grant 3,984 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-23 Grant 3,984 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-23 Grant 3,984 $0.00
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
2026-02-23 Grant 3,984 $0.00
Keenova Therapeutics PLC NONE
Common Stock
2026-01-07 Buy 250,000 $92.25 23,062,500
Keenova Therapeutics PLC NONE
Ordinary Shares
2026-01-01 Option exercise 1,808
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com